{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06046222",
            "orgStudyIdInfo": {
                "id": "NS229-P2-01"
            },
            "organization": {
                "fullName": "NS Pharma, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis",
            "officialTitle": "A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of NS-229 in the Treatment of Eosinophilic Granulomatosis With Polyangiitis",
            "therapeuticArea": [
                "Rare Diseases",
                "Other"
            ],
            "study": "trial-of-efficacy-and-safety-of-ns-versus-placebo-in-patients-with-eosinophilic-granulomatosis-with-polyangiitis"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-09-14",
            "studyFirstSubmitQcDate": "2023-09-14",
            "studyFirstPostDateStruct": {
                "date": "2023-09-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "NS Pharma, Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Nippon Shinyaku Co., Ltd.",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will enroll male and female subjects who are 18 years of age or older with Eosinophilic Granulomatosis With Polyangiitis.",
            "detailedDescription": "The purpose of this randomized, double-blind study is to investigate the efficacy and safety of NS229 compared with placebo over a 28-week study treatment period in subjects with Eosinophilic Granulomatosis with Polyangiitis (EGPA) receiving background corticosteroid therapy with or without mepolizumab therapy. During the treatment period corticosteroid dose will be tapered.\n\nThe key outcomes in the study focus on evaluation of clinical remission, defined as Birmingham Vasculitis Activity Score (BVAS)=0 with a corticosteroid dose of \\<=4 mg/day prednisolone/prednisone."
        },
        "conditionsModule": {
            "conditions": [
                "Eosinophilic Granulomatosis With Polyangiitis",
                "Churg-Strauss Syndrome"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 45,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "NS-229",
                    "type": "EXPERIMENTAL",
                    "description": "Self-administer NS-229 in consecutive 28 weeks.",
                    "interventionNames": [
                        "Drug: NS-229"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Self-administer matching placebo in consecutive 28 weeks.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "NS-229",
                    "description": "Experimental",
                    "armGroupLabels": [
                        "NS-229"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo comparator",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "The proportion of subjects in remission [OGC 4.0]",
                    "description": "The proportion of subjects in remission (oral glucocorticoid \\[OGC\\] 4.0) at Week 28 of the study treatment period.\n\nDefinition of remission (OGC 4.0): BVAS of 0 AND OGC dose of prednisolone/prednisone \u22644 mg/day",
                    "timeFrame": "From Baseline to week 28"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "The proportion of subjects in remission [OGC 7.5]",
                    "description": "The proportion of subjects in remission (OGC 7.5) at Week 28 of the study treatment period Definition of remission (OGC 7.5): BVAS of 0 AND OGC dose of prednisolone/prednisone \u22647.5 mg/day",
                    "timeFrame": "From Baseline to week 28"
                },
                {
                    "measure": "Time to first relapse of EGPA",
                    "description": "Relapse of EGPA will be defined as active disease since the last visit after remission (OGC 4.0) was achieved, characterized by:\n\n1. Active vasculitis (BVAS of \\>0); OR\n2. Signs and/or symptoms of active asthma with a corresponding worsening in answers on the 6-item Asthma Control Questionnaire (compared with the most recent previous results); OR\n3. Active nasal and/or sinus disease (attributable to EGPA) with a corresponding worsening in at least 1 of the answers on the sinonasal symptom questionnaire (compared with the most recent previous assessment).",
                    "timeFrame": "Up to Week 28"
                },
                {
                    "measure": "Time to first worsening of EGPA",
                    "description": "Worsening of EGPA will be defined as worsening of active disease since the last visit, characterized by:\n\n1. Active vasculitis (BVAS \\>0) and the score greater than the previous visit; OR\n2. Signs and/or symptoms of active asthma with a corresponding worsening in answers on the 6-item Asthma Control Questionnaire (compared to the most recent previous score); OR\n3. Active nasal and/or sinus disease (attributable to EGPA) with a corresponding worsening in at least 1 of the answers on the sinonasal symptom questionnaire (compared to the most recent previous assessment).",
                    "timeFrame": "Up to Week 28"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Ability to provide written informed consent prior to participation in the study.\n* Male or female subjects aged \u226518 years at the time the informed consent form is signed.\n* Diagnosis of EGPA: Subjects who have been diagnosed with EGPA based on the history or presence of eosinophilia plus at least a history or presence of 2 of additional features of EGPA.\n* Subjects receive background OGC dose of \u22657.5 mg/day with or without stable treatment with mepolizumab.\n* Use of adequate contraception.\n* Other inclusion criteria may apply.\n\nExclusion Criteria:\n\n* Current diagnosis of either granulomatosis with polyangiitis or microscopic polyangiitis\n* Imminently life-threatening EGPA at the time of screening.\n* History or presence of any form of cancer within 5 years prior to screening.\n* Serious liver, renal, blood, or psychiatric disease\n* Severe or clinically significant cardiovascular disease uncontrolled with standard treatment\n* Active systemic infections (including TB, pneumonia, Pneumocystis pneumonia, sepsis, and opportunistic infections)\n* Parasitic infection: Subjects with a known parasitic infestation within 6 months prior to screening.\n* HIV positive status\n* Active hepatitis due to hepatitis B virus or hepatitis C virus\n* Known history or presence of venous thromboembolism/venous thrombotic events (deep vein thrombosis and/or pulmonary embolus)\n* laboratory parameter exclusions:\n\n  1. Estimated glomerular filtration rate of \\<30 mL/min/1.73 m2 by Chronic Kidney Disease Epidemiology Collaboration equations\n  2. WBC count \\<4 \u00d7 109/L\n  3. Absolute lymphocyte count \\<500 cells/mm3\n  4. Absolute neutrophil count \\<1000 cells/mm3\n  5. Platelet count \\<120,000/mm3\n  6. Hemoglobin \\<8 g/dL (\\<80 g/L)\n* Subjects who are pregnant, breastfeeding, or planning to become pregnant during the time of study participation\n* History of clinically significant drug or alcohol abuse within the last 6 months\n* Other exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "NS Pharma, Inc.",
                    "role": "CONTACT",
                    "phone": "1-866-677-4276",
                    "email": "trialinfo@nspharma.com"
                }
            ],
            "locations": [
                {
                    "facility": "National Jewish Health",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80206",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "The Ohio State University Wexner Medical Center",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "University of Pennsylvania",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Vanderbilt University Medical Center",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37232",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "St Joseph's Healthcare Hamilton",
                    "status": "RECRUITING",
                    "city": "Hamilton",
                    "state": "Ontario",
                    "zip": "L8N4A6",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.25011,
                        "lon": -79.84963
                    }
                },
                {
                    "facility": "CHU Nice",
                    "status": "RECRUITING",
                    "city": "Nice",
                    "zip": "06202",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.70313,
                        "lon": 7.26608
                    }
                },
                {
                    "facility": "Hopital Cochin",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "zip": "75014",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Chu Rangueil",
                    "status": "RECRUITING",
                    "city": "Toulouse",
                    "zip": "31059",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.60426,
                        "lon": 1.44367
                    }
                },
                {
                    "facility": "Medius Kliniken gGmbh",
                    "status": "RECRUITING",
                    "city": "Kirchheim Unter Teck",
                    "state": "Studienzentrale",
                    "zip": "73230",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 48.64683,
                        "lon": 9.45378
                    }
                },
                {
                    "facility": "Hospital of the University of Occupational and Environmental Health, Japan",
                    "status": "RECRUITING",
                    "city": "Kitakyushu",
                    "state": "Fukuoka",
                    "zip": "807-8555",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 33.85181,
                        "lon": 130.85034
                    }
                },
                {
                    "facility": "NHO Sagamihara National Hospital",
                    "status": "RECRUITING",
                    "city": "Sagamihara",
                    "state": "Kanagawa",
                    "zip": "252-0392",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.54899,
                        "lon": 139.26064
                    }
                },
                {
                    "facility": "Tohoku University Hospital",
                    "status": "RECRUITING",
                    "city": "Sendai",
                    "state": "Miyagi",
                    "zip": "980-8574",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 38.26667,
                        "lon": 140.86667
                    }
                },
                {
                    "facility": "Saitama Medical Center",
                    "status": "RECRUITING",
                    "city": "Kawagoe",
                    "state": "Saitama",
                    "zip": "350-8550",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.90861,
                        "lon": 139.48528
                    }
                },
                {
                    "facility": "Juntendo University Hospital",
                    "status": "RECRUITING",
                    "city": "Bunkyo-ku",
                    "state": "Tokyo",
                    "zip": "113-8431",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.37517,
                        "lon": 139.92991
                    }
                },
                {
                    "facility": "Kyorin University Hospital",
                    "status": "RECRUITING",
                    "city": "Mitaka",
                    "state": "Tokyo",
                    "zip": "181-8611",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.68351,
                        "lon": 139.55963
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "Submission to the FDA"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014890",
                    "term": "Granulomatosis with Polyangiitis"
                },
                {
                    "id": "D000056647",
                    "term": "Systemic Vasculitis"
                },
                {
                    "id": "D000015267",
                    "term": "Churg-Strauss Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014657",
                    "term": "Vasculitis"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000017563",
                    "term": "Lung Diseases, Interstitial"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000056648",
                    "term": "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"
                },
                {
                    "id": "D000017445",
                    "term": "Skin Diseases, Vascular"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000006099",
                    "term": "Granuloma"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M17630",
                    "name": "Granulomatosis with Polyangiitis",
                    "asFound": "Granulomatosis With Polyangiitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17968",
                    "name": "Churg-Strauss Syndrome",
                    "asFound": "Eosinophilic Granulomatosis With Polyangiitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28526",
                    "name": "Systemic Vasculitis",
                    "asFound": "Polyangiitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17405",
                    "name": "Vasculitis",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M19813",
                    "name": "Lung Diseases, Interstitial",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M28527",
                    "name": "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M19714",
                    "name": "Skin Diseases, Vascular",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9202",
                    "name": "Granuloma",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2610",
                    "name": "Granulomatosis With Polyangiitis",
                    "asFound": "Granulomatosis With Polyangiitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2090",
                    "name": "Eosinophilic Granulomatosis With Polyangiitis",
                    "asFound": "Eosinophilic Granulomatosis With Polyangiitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T285",
                    "name": "Allergic Angiitis",
                    "asFound": "Eosinophilic Granulomatosis With Polyangiitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T375",
                    "name": "ANCA-associated Vasculitis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}